Report Faults FDA for Failure to Follow through on Drugs
Filed Under: In brief
“The Food and Drug Administration has allowed drugs for cancer and other diseases to stay on the market even when follow-up studies showed they didn’t extend patients’ lives, say congressional investigators. A report due out Monday from the Government Accountability Office also shows that the FDA has never pulled a drug off the market due to a lack of required follow-up about its actual benefits — even when such information is more than a decade overdue.” (USA Today, Monday)
The FDA imprimatur gives a false sense of security.
FEE Timely Classic
“A World Without the FDA” by Russell Roberts
